Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Neovasc Inc (NQ: NVCN ) 30.03 UNCHANGED Last Price Updated: 4:00 PM EDT, Apr 10, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Neovasc Inc < Previous 1 2 Next > A Bull Market Is Coming: 1 Outstanding Growth Stock Down 36% to Buy and Hold February 22, 2023 This up-and-coming medical technology star is set up to deliver market-beating gains for its long-term investors. Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023 January 18, 2023 Via Benzinga Earnings Scheduled For August 11, 2022 August 11, 2022 Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. Via Benzinga Neovasc: Q4 Earnings Insights March 10, 2022 Neovasc (NASDAQ:NVCN) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Neovasc beat... Via Benzinga Earnings Scheduled For March 10, 2022 March 10, 2022 Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares... Via Benzinga Why Are Neovasc Shares Moving Higher On Thursday? September 16, 2021 The Via Benzinga Nasdaq Edges Higher; Neovasc Shares Jump January 17, 2023 U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Tuesday. Via Benzinga Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session January 17, 2023 Gainers Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program... Via Benzinga Why Neovasc Shares Are Trading Higher Today January 17, 2023 Neovasc Inc. (NASDAQ: NVCN) shares are trading higher after ShockWave Medical, Inc. (NASDAQ: SWAV) announced it would acquire the company. Via Benzinga Earnings Scheduled For August 10, 2021 August 10, 2021 Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:... Via Benzinga The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight August 08, 2021 Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... Via Benzinga Exposures Product Safety Dow Dinged As Big Bank Earnings Weigh January 17, 2023 A round of earnings from the banking sector is weighing today, stifling Wall Street's early 2023 momentum. Via Talk Markets Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views January 17, 2023 U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 300 points on Tuesday. Via Benzinga Dow Drops Over 150 Points; Goldman Sachs Profit Misses Expectations January 17, 2023 U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Tuesday. Via Benzinga Shockwave Medical Seeks To Bolster Its Cardiovascular Disease Portfolio With Neovasc Acquisition January 17, 2023 Via Benzinga Stocks That Hit 52-Week Highs On Monday May 02, 2022 Monday's session saw 22 companies set new 52-week highs. Via Benzinga Stocks That Hit 52-Week Lows On Friday November 25, 2022 On Friday, 68 companies reached new 52-week highs. Via Benzinga Neovasc Receives FDA Approval for COSIRA-II Clinical Trial October 19, 2021 The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Neovasc Inc. (... Via Benzinga Exposures Product Safety Earnings Scheduled For May 12, 2022 May 12, 2022 Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter. Via Benzinga 74 Biggest Movers From Yesterday April 29, 2022 Gainers T Stamp Inc. (NASDAQ: IDAI) shares surged 123.8% to close at $4.70 on Thursday. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric... Via Benzinga Real World Study Shows Neovasc's Reducer Is Safe, Efficacious In Patients With Refractory Angina June 18, 2021 Neovasc Inc (NASDAQ: NVCN) has announced the publication of an article highlighting the long-term outcomes of patients suffering from refractory angina treated... Via Benzinga The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg March 06, 2022 Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (... Via Benzinga 40 Stocks Moving In Wednesday's Mid-Day Session June 02, 2021 Gainers BriaCell Therapeutics Corp. (NASDAQ: BCTX) shares jumped 147.3% to $7.86 after the company provided an update on the overall survival (OS) data on its previously... Via Benzinga The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data November 09, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... Via Benzinga 22 Stocks Moving in Wednesday's Pre-Market Session June 02, 2021 Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) rose 37.2% to $1.99 in pre-market trading after the company said it received orphan drug designation from the European... Via Benzinga The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs October 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results October 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... Via Benzinga The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts August 10, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (... Via Benzinga Exposures COVID-19 66 Biggest Movers From Yesterday June 03, 2021 Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) surged 95.2% to close at $62.55 on Wednesday amid renewed interest from retail investors. AMC Entertainment shares jumped... Via Benzinga The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing May 26, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25) ESSA Pharma Inc. (NASDAQ:... Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.